Key facts
- Manuals
- 1
- Languages
- ZH
- Last added
- 2026-10-16
Featured Bristol-Myers Squibb manuals

SPRYCEL Dasatinib Oral Tablets Patient Information
This document is the patient information leaflet for SPRYCEL (dasatinib), an oral tablet used to treat certain types of leukemia. It outlines the approved uses for adults with Philadelphia chromosome-positive chronic myeloid leukemia (Ph+ CML) and Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL). The text details specific dosing regimens based on the type of leukemia and patient history, such as 100 mg daily for chronic phase CML and 140 mg daily for accelerated phase or Ph+ ALL. This manual is written in Chinese.
Covers: Indications and Usage · Dosage and Administration · Contraindications · Warnings and Precautions · Adverse Reactions · Drug Interactions
Latest Bristol-Myers Squibb manuals
SPRYCEL Dasatinib Oral Tablets Patient Information
User Manual 31 pages · 1 MB · ZHThis document provides patient information for SPRYCEL (dasatinib) oral tablets, including indications, dosage, administration, warnings, and adverse reactions.
Which document do I need?
User Manual
Day-to-day operation, settings and troubleshooting. Start here if the product is already set up.
Questions answered in Bristol-Myers Squibb manuals
What is the recommended starting dose for chronic phase CML?
The recommended starting dose is 100 mg taken orally once daily.
How should SPRYCEL tablets be taken?
Tablets should be swallowed whole and should not be crushed or sliced. They can be taken with or without food.
